New vaccine hope for leading viral cause of birth defects

April 10, 2014, Cardiff University
New vaccine hope for leading viral cause of birth defects

(Medical Xpress)—Experts in infection and immunity have made a path-finding discovery that could lead to the development of a vaccine for a health-ravaging virus that affects around 50% of adults in the UK.

Cytomegalovirus (CMV) is the leading viral cause of congenital birth defects, with 1 in 750 babies in the UK being born with permanent disabilities - these include blindness, deafness and brain damage - as a result of infection within the womb.

Scientists from Cardiff have uncovered a novel defence mechanism to control disease, using the most common form of white blood cell – neutrophils.

Although it has long been known that neutrophils are important in killing bacterial infections, it was largely thought that they were specifically designed for this cause; the fact that they can also fight a viral attack is a major breakthrough according to Dr Ian Humphreys from the University's School of Medicine:

"Our study shows that neutrophils protect our organs from CMV by producing a protein called TRAIL that can directly kill virus-infected cells. Our body attracts the neutrophils to where the virus is replicating by producing the protein IL-22, which acts as a homing signal.

"Disease may actually be prevented if we can teach the immune system to quickly send antiviral to the first site of infection. We are now developing a that may protect the body against CMV. Our findings may also have implications for other destructive viruses such as flu, hepatitis and even HIV."

Dr Chris Benedict from the La Jolla Institute for Allergy and Immunology (San Diego, California) said:

"Neutrophils are the rapid-response arm of the immune system's war against infection. The discovery of a new molecular mechanism for neutrophil mobilization and execution in the fight against CMV is very exciting, and provides key insights for developing more effective vaccines and therapies to combat this little-known viral pathogen."

Currently there is no known treatment for CMV. Given that the virus spreads via bodily secretions such as urine, saliva and breast milk, scientists at Cardiff sought to understand how to protect mucosal sites from , and how to prevent the virus taking its grip in other important organs such as the liver.

The is also a major reason behind life-threatening diseases in bone marrow and organ transplant recipients and is known to have a major impact on the immune system of even the healthiest of adults.

The paper is published today in the journal Cell Host & Microbe.

Explore further: People with leukaemia are more prone to infection – but not from one particular herpes virus

Related Stories

People with leukaemia are more prone to infection – but not from one particular herpes virus

March 19, 2014
People with chronic lymphocytic leukaemia (CLL) are essentially more prone to infections such as varicella, influenza or pneumococci due to the reduction in the number of antibodies that their condition causes. Researchers ...

Study advances fight against leading infectious cause of congenital birth defects

March 13, 2013
A virus most people probably have never heard of, but that the majority of us carry, is the No. 1 infectious cause of congenital birth defects in the U.S. today. Because of cytomegalovirus (CMV) infection during in utero ...

Novel vaccine approach to human cytomegalovirus found effective

September 18, 2013
An experimental vaccine against human cytomegalovirus (CMV) infection, which endangers the developing fetus, organ transplant recipients, patients with HIV and others who have a weakened immune system, proved safe and more ...

Researchers identify protein that helps control common viral infection

March 26, 2014
Infectious disease specialists at the Johns Hopkins Children's Center have identified a protein that regulates the body's immune response to cytomegalovirus (CMV), a common pathogen that causes lifelong infections and can ...

New study finds novel population of neutrophils

March 24, 2014
Case Western Reserve University researchers have discovered a novel population of neutrophils, which are the body's infection control workhorses. These cells have an enhanced microbial killing ability and are thereby better ...

Researchers show long-term consequences of chronic virus infection

August 16, 2012
The cytomegalovirus (CMV) is a member of the herpesvirus family. Although most people carry CMV for life, it hardly ever makes them sick. Researchers from the Helmholtz Centre for Infection Research and from the USA have ...

Recommended for you

Patients receive most opioids at the doctor's office, not the ER

January 16, 2018
Around the country, state legislatures and hospitals have tightened emergency room prescribing guidelines for opioids to curb the addiction epidemic, but a new USC study shows that approach diverts attention from the main ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

Price tag on gene therapy for rare form of blindness: $850K

January 3, 2018
A first-of-its kind genetic treatment for blindness will cost $850,000 per patient, making it one of the most expensive medicines in the world and raising questions about the affordability of a coming wave of similar gene-targeting ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.